The forecast for measles-containing-vaccine second-dose (MCV2) immunization coverage in India shows a gradual increase from 90% in 2024 to 92% in 2028. Assuming that the coverage level in 2023 stood at a slightly lower benchmark, this projected data indicates a steady, albeit slow, growth trend.
Year-on-year, the growth shows a consistent increase of approximately 1% from 2024 to 2028, suggesting a stable upward trajectory. Over the five-year period, the compound annual growth rate (CAGR) reveals sustained improvement in MCV2 coverage for children of the nationally recommended age.
Future trends to watch for include government policy interventions, healthcare infrastructure development, and public awareness campaigns which could significantly impact the vaccine coverage trajectory. Additionally, monitoring resistance or acceptance towards vaccinations could provide insights for further growth potential.
